COMMUNIQUÉS West-GlobeNewswire

Bauman Medical to Present New Head-to-Head Data Comparing Autologous Hair Follicle Secretome (aHFS) to PRP at ISHRS 2026 World Congress in Rio de Janeiro
23/09/2026
Dr. Alan J. Bauman's accepted oral abstract shows a cell-free, patient-derived regenerative therapy substantially outperforming platelet-rich plasma across growth-factor, exosome, and clinical-recovery metrics with age- [...]
Retrieve Medical Announces Coming Integration of Wearable Health Data into Retrieve Passport
23/09/2026
New capability will bring wearable health and wellness data together with medical records in one secure platform BEDMINSTER, N.J., Sept. 23, 2026 (GLOBE NEWSWIRE) -- Retrieve Medical Holdings, Inc. (OTC:RMHI) today [...]
Audiologists and Speech-Language Pathologists Take to Capitol Hill To Advocate for Policies That Support Patient Access to Essential Care
23/09/2026
ASHA Members Bring More Than 6,000 Constituent Letters to Congress as Continued Medicare Payment Pressures Threaten Availability of Needed Services Washington, DC, Sept. 23, 2026 (GLOBE NEWSWIRE) -- More than 150 [...]
NexLife Includes a Licensed Doctor, a Nutrition Plan and Health Check-Ins After Treatment Starts in Every Compounded GLP-1 Subscription
23/09/2026
Every NexLife compounded GLP-1 subscription includes a doctor's review, a personalized nutrition plan and a 1:1 fitness coaching call alongside the medication. Ongoing care runs through Care 360, giving members 24/7 [...]
New model-based analysis further supports the potential of TECVAYLI®▼ (teclistamab) plus daratumumab to redefine long-term survival expectations in early line relapsed/refractory multiple myeloma
23/09/2026
Analysis showed ~87% of patients treated with TECVAYLI ® ▼ plus daratumumab as early as second line were estimated to have comparable mortality risk to the general population 1 A separate analysis shows the survival [...]
Smith+Nephew launches the new EVOS™ PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting, expanding the EVOS Plating Platform for pelvic and acetabular fracture management
23/09/2026
The All-in-one system combines plates, cannulated screws and specialized instrumentation to streamline complex pelvic surgery Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the [...]
TwitchView® Quantitative Neuromuscular Monitoring Now Standardized Across Two Additional Midwest Academic Health Systems
23/09/2026
SEATTLE, Sept. 23, 2026 (GLOBE NEWSWIRE) -- Blink Anesthesia announced today that two additional academic integrated delivery networks (IDNs) in the Midwest have standardized the TwitchView® Train of Four (TOF) Monitor [...]
MULTIMEDIA UPDATE: Smith+Nephew launches the new EVOS™ PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting, expanding the EVOS Plating Platform for pelvic and acetabular fracture management
23/09/2026
The All-in-one system combines plates, cannulated screws and specialized instrumentation to streamline complex pelvic surgery Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the [...]
Clareo Plastic Surgery Recognized as Best Plastic Surgeon in Boston
23/09/2026
Pouted Magazine Ranks Clareo No. 1 Among Five Boston-Area Plastic Surgery Practices Chestnut Hill, MA, Sept. 23, 2026 (GLOBE NEWSWIRE) -- Clareo Plastic Surgery has earned the top spot in Pouted Magazine's 2026 [...]
Roivant Announces Topline Results from Proof-of-Concept Study of IMVT-1402 in Cutaneous Lupus Erythematosus
23/09/2026
Immunovant’s proof-of-concept study of IMVT-1402 (imeroprubart) in cutaneous lupus erythematosus (CLE) did not achieve statistical significance on the primary endpoint of Cutaneous Lupus Erythematosus Disease Area and [...]
AC Immune Reports Positive Safety & Immunogenicity at week-100 in Part 1 of VacSYn Phase 2 Trial of ACI-7104
23/09/2026
All primary endpoints of the study were met, with ACI-7104 shown to be generally safe and well tolerated Strong immunogenicity demonstrated, with 100% response rate after three immunizations Clear antibody penetration [...]
Grey Matters Announces the Closing of its Equity and Convertible Debenture Private Placement totalling CAD $1.12 Million
23/09/2026
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Sept. 23, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: [...]
Seer and Nanyang Technological University to Present Early Findings from Landmark PRECISE-SG100K Proteomics Study at HUPO 2026
23/09/2026
John Chambers, PhD, and Nilanjana Sadhu, PhD, to share early insights from pioneering population-scale proteomic study of 10,000 participants in Singapore REDWOOD CITY, Calif., Sept. 23, 2026 (GLOBE NEWSWIRE) -- Seer, [...]
Immunovant Announces Topline Results from Proof-of-Concept Study of IMVT-1402 in Cutaneous Lupus Erythematosus
23/09/2026
Immunovant’s proof-of-concept study of IMVT-1402 (imeroprubart) in cutaneous lupus erythematosus (CLE) did not achieve statistical significance on the primary endpoint of Cutaneous Lupus Erythematosus Disease Area and [...]
Psyence BioMed Announces Strategic Ibogaine Investment
23/09/2026
Transactions include an investment of up to US$5 million in PsyLabs and an approximately US$9 million value-matched share exchange Highlights The Company is actively advancing plans for a potential ibogaine clinical [...]
Verano to Report Third Quarter 2026 Financial Results on October 29, 2026
23/09/2026
CHICAGO, Sept. 23, 2026 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNO) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced that it plans to release financial [...]
Oruka Therapeutics Announces Positive Week 28 Data for ORKA-001 from the Ongoing EVERLAST-A Trial Showing Deepening of Responses Without Additional Dosing
23/09/2026
PASI 100 increased to 71.4% and PASI 90 increased to 87.3%, despite no dosing after Week 4 Placebo crossover patients reached PASI 100 and PASI 90 rates similar to those initially dosed with ORKA-001 ORKA-001 maintained [...]
Lexeo Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum
23/09/2026
NEW YORK, Sept. 23, 2026 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO) a clinical stage company focused on reshaping the path of genetic diseases with high unmet need, today announced that the Company will [...]
Avalo Therapeutics to Present at the European Academy of Dermatology and Venereology (EADV) 2026 Congress
23/09/2026
WAYNE, Pa., Sept. 23, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated [...]

Pages